APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,639,291 | +47.3% | 105,810 | +6.7% | 0.17% | +73.0% |
| Q1 2023 | $6,543,892 | +117.0% | 99,210 | +70.1% | 0.10% | +170.3% |
| Q4 2022 | $3,015,210 | -88.5% | 58,310 | -84.8% | 0.04% | -88.2% |
| Q3 2022 | $26,132,000 | +540.0% | 382,600 | +323.7% | 0.31% | +552.1% |
| Q2 2022 | $4,083,000 | +66.7% | 90,300 | +87.3% | 0.05% | +84.6% |
| Q1 2022 | $2,449,000 | -40.2% | 48,200 | -44.3% | 0.03% | -39.5% |
| Q4 2021 | $4,094,000 | +343.6% | 86,600 | +209.3% | 0.04% | +377.8% |
| Q3 2021 | $923,000 | – | 28,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |